-       Report 
   - April 2025
    -  114 Pages 
    China
   
   From       €1615EUR$1,800USD£1,418GBP 
                -       Report 
   - October 2023
    -  109 Pages 
    Global
   
   From       €3500EUR$4,178USD£3,179GBP 
                -       Report 
   - June 2023
    -  84 Pages 
    Global
   
   From       €3500EUR$4,178USD£3,179GBP 
                      The Sleep Disorder Drug market is a subset of the Central Nervous System Drugs market. It includes drugs used to treat a variety of sleep disorders, such as insomnia, narcolepsy, and sleep apnea. These drugs are typically classified as hypnotics, sedatives, or anxiolytics, and can be prescribed in the form of tablets, capsules, or liquids. Commonly prescribed sleep disorder drugs include benzodiazepines, non-benzodiazepines, and melatonin receptor agonists.
The Sleep Disorder Drug market is highly    competitive, with many companies offering a variety of products. Some of the major players in the market include Pfizer, Sanofi, Merck, GlaxoSmithKline, Novartis, and Takeda. Other companies include Sunovion, Jazz Pharmaceuticals, and Teva Pharmaceuticals. Show Less   Read more